Seroepidemiology (2018-2024) and Epidemic Spread of an Emerging Human Parvovirus B19 Genotype 1 (subtype 1a2) Variant in Hungary, 2023/2024

Overview

Journal Arch Virol

Date 2025 Feb 2

PMID 39893614

Authors

Fruzsina Toth

Timea Moser

Akos Boros

Benigna Balazs

Karoly Takats

Peter Pankovics

Gabor Reuter

Affiliations

Soon will be listed here.

Abstract

An unusually large number of human parvovirus B19 (B19V) infections were reported in European countries in 2023/2024, but the genetic background of this B19V epidemic strain is unknown. In this study, there was a larger number of confirmed B19V infections (five in 2021, eight in 2023, and 59 in 2024) and higher IgG seroprevalence (41.4% in 2022 and 54.3% in 2024) in Transdanubia, Hungary, in 2024 compared to 2018-2023. A B19V genotype 1a2 variant (prototype, 1338/HUN/2024, PQ155933) with common and unique nucleotide insertions in the untranslated regions of the genome and nonsynonymous and synonymous mutations in the coding region (NS1 and VP1) could be responsible to the ongoing B19V epidemic in Europe.

References

Nordholm A, Moller F, Fischer Ravn S, Flink Sorensen L, Moltke-Prehn A, Elskaer Mollerup J . Epidemic of parvovirus B19 and disease severity in pregnant people, Denmark, January to March 2024. Euro Surveill. 2024; 29(24). PMC: 11177569. DOI: 10.2807/1560-7917.ES.2024.29.24.2400299. View

Vukovic V, Patic A, Ristic M, Kovacevic G, Hrnjakovic Cvjetkovic I, Petrovic V . Seroepidemiology of Human Parvovirus B19 Infection among the Population of Vojvodina, Serbia, over a 16-Year Period (2008-2023). Viruses. 2024; 16(2). PMC: 10893261. DOI: 10.3390/v16020180. View

Jiang H, Qiu Q, Zhou Y, Zhang Y, Xu W, Cui A . The epidemiological and genetic characteristics of human parvovirus B19 in patients with febrile rash illnesses in China. Sci Rep. 2023; 13(1):15913. PMC: 10517975. DOI: 10.1038/s41598-023-43158-y. View

Lin L, Liu Y, Tang X, He D . The Disease Severity and Clinical Outcomes of the SARS-CoV-2 Variants of Concern. Front Public Health. 2021; 9:775224. PMC: 8669511. DOI: 10.3389/fpubh.2021.775224. View

Molenaar-de Backer M, Lukashov V, van Binnendijk R, Boot H, Zaaijer H . Global co-existence of two evolutionary lineages of parvovirus B19 1a, different in genome-wide synonymous positions. PLoS One. 2012; 7(8):e43206. PMC: 3418230. DOI: 10.1371/journal.pone.0043206. View

Cotmore S, Agbandje-Mckenna M, Canuti M, Chiorini J, Eis-Hubinger A, Hughes J . ICTV Virus Taxonomy Profile: Parvoviridae. J Gen Virol. 2019; 100(3):367-368. PMC: 6537627. DOI: 10.1099/jgv.0.001212. View

Mor O, Wax M, Arami S, Yitzhaki M, Kriger O, Erster O . Parvovirus B19 Outbreak in Israel: Retrospective Molecular Analysis from 2010 to 2023. Viruses. 2024; 16(3). PMC: 10974090. DOI: 10.3390/v16030480. View

Williams S, Ratcliff J, Nguyen D, Simmonds P, Harvala H . Detection frequencies and viral load distribution of parvovirus B19 DNA in blood and plasma donations in England. Transfus Med. 2022; 32(5):402-409. PMC: 9796365. DOI: 10.1111/tme.12893. View

Pedersen C, Westergaard T, Jensen I, Lebech M, Andersen P, Aaby P . Risk factors for parvovirus B19 infection in pregnancy. JAMA. 1999; 281(12):1099-105. DOI: 10.1001/jama.281.12.1099. View

10.

Dittmer F, Guimaraes C, Peixoto A, Pontes K, Bonasoni M, Tonni G . Parvovirus B19 Infection and Pregnancy: Review of the Current Knowledge. J Pers Med. 2024; 14(2). PMC: 10890458. DOI: 10.3390/jpm14020139. View

11.

Juhasz Z, Tiszlavicz L, Kele B, Terhes G, Deak J, Rudas L . Sudden cardiac death from parvovirus B19 myocarditis in a young man with Brugada syndrome. J Forensic Leg Med. 2014; 25:8-13. DOI: 10.1016/j.jflm.2014.04.018. View

12.

Abu-Raya B, Vineta Paramo M, Reicherz F, Lavoie P . Why has the epidemiology of RSV changed during the COVID-19 pandemic?. EClinicalMedicine. 2023; 61:102089. PMC: 10359735. DOI: 10.1016/j.eclinm.2023.102089. View

13.

Terhes G, Jenei M, Bereg E, Turi S, Deak J . Neurologic consequence of a parvovirus B19 infection. J Clin Virol. 2012; 56(2):156-8. DOI: 10.1016/j.jcv.2012.10.018. View

14.

Gallinella G, Venturoli S, Manaresi E, Musiani M, Zerbini M . B19 virus genome diversity: epidemiological and clinical correlations. J Clin Virol. 2003; 28(1):1-13. DOI: 10.1016/s1386-6532(03)00120-3. View

15.

Carabelli A, Peacock T, Thorne L, Harvey W, Hughes J, Peacock S . SARS-CoV-2 variant biology: immune escape, transmission and fitness. Nat Rev Microbiol. 2023; 21(3):162-177. PMC: 9847462. DOI: 10.1038/s41579-022-00841-7. View

16.

Mossong J, Hens N, Friederichs V, Davidkin I, Broman M, Litwinska B . Parvovirus B19 infection in five European countries: seroepidemiology, force of infection and maternal risk of infection. Epidemiol Infect. 2007; 136(8):1059-68. PMC: 2870907. DOI: 10.1017/S0950268807009661. View

17.

Servant A, Laperche S, Lallemand F, Marinho V, De Saint Maur G, Meritet J . Genetic diversity within human erythroviruses: identification of three genotypes. J Virol. 2002; 76(18):9124-34. PMC: 136440. DOI: 10.1128/jvi.76.18.9124-9134.2002. View

18.

dHumieres C, Fouillet A, Verdurme L, Lakoussan S, Gallien Y, Coignard C . An unusual outbreak of parvovirus B19 infections, France, 2023 to 2024. Euro Surveill. 2024; 29(25). PMC: 11191415. DOI: 10.2807/1560-7917.ES.2024.29.25.2400339. View

19.

Hubschen J, Mihneva Z, Mentis A, Schneider F, Aboudy Y, Grossman Z . Phylogenetic analysis of human parvovirus b19 sequences from eleven different countries confirms the predominance of genotype 1 and suggests the spread of genotype 3b. J Clin Microbiol. 2009; 47(11):3735-8. PMC: 2772644. DOI: 10.1128/JCM.01201-09. View

20.

Jain A, Kant R . Genotypes of erythrovirus B19, their geographical distribution & circulation in cases with various clinical manifestations. Indian J Med Res. 2018; 147(3):239-247. PMC: 6022381. DOI: 10.4103/ijmr.IJMR_1816_16. View